Although elevated numbers of CD8+ T cells in the TME are positively associated with good prognoses in cancer [52], tumor-killing activity by these CD8+ T cells is generally compromised due to the hostile intratumoral metabolic environment in tumors [53]. Here, CD8A is linked to neoplasm.